McKinney Eoin F - Cambridge Institute for Medical Research and Department of Medicine, University of Cambridge School of Clinical Medicine

基本信息

浏览量：36

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 68 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Using Machine Learning to Individualize Treatment Effect Estimation: Challenges and Opportunities

Alicia Curth,Richard W. Peck,Eoin Mckinney,James Weatherall,Mihaela van Der Schaar

CLINICAL PHARMACOLOGY & THERAPEUTICS（2024）

引用0浏览0WOS引用

A Biomarker-Stratified Comparison of Top-Down Versus Accelerated Step-Up Treatment Strategies for Patients with Newly Diagnosed Crohn's Disease (PROFILE): a Multicentre, Open-Label Randomised Controlled Trial

Nurulamin M. Noor,James C. Lee,Simon Bond,Francis Dowling,Biljana Brezina,Kamal Patel,Tariq Ahmad, Paul J. Banim,James W. Berrill,Rachel Cooney,Juan De La Revilla Negro,Shanika de Silva,Shahida Din,Dharmaraj Durai,John N. Gordon,Peter M. Irving,Matthew Johnson,Alexandra J. Kent,Klaartje B. Kok,Gordon W. Moran,Craig Mowat,Pritash Patel,Chris S. Probert,Tim Raine, Rebecca Saich, Abigail Seward, Dan Sharpstone,Melissa A. Smith,Sreedhar Subramanian,Sara S. Upponi, Alan Wiles,Horace R. T. Williams, Gijs R. van den Brink,Severine Vermeire,Vipul Jairath,Geert R. D'Haens,Eoin F. McKinney,Paul A. Lyons,James Lindsay,Nicholas A. Kennedy, Kenneth G. C. Smith,Miles Parkes

LANCET GASTROENTEROLOGY & HEPATOLOGYno. 5 (2024): 415-427

引用0浏览0WOS引用

OP01 PROFILE: a Multi-Centre, Randomised, Open-Label, Biomarker-Stratified Clinical Trial of Treatment Strategies for Patients with Newly-Diagnosed Crohn’s Disease

N. Noor, J. Lee, S. Bond,F. Dowling, B. Brezina, K. Patel,T. Ahmad,P. Banim,R. Cooney,J. De la Revilla Negro,S. de Silva,S. Din,D. Durai, J. Gordon,P. Irving, M. Johnson,A. Kent,K. B. Kok,G. Moran, P. Patel,C. Probert,T. Raine, R. Saich, A. Seward,D. Sharpstone, M. Smith, S. Subramanian,S. Upponi,A. Wiles, G. Van den Brink, S. Vermeire,V. Jairath,G. D'Haens,E. McKinney,P. Lyons, J. Lindsay,N. Kennedy, K. Smith,M. Parkes

JOURNAL OF CROHNS & COLITIS (2024): I1-I2

引用0浏览0引用

Leveraging Pleiotropy Identifies Common-Variant Associations with Selective IgA Deficiency

Thomas W. Willis,Effrossyni Gkrania-Klotsas,Nicholas J. Wareham,Eoin F. McKinney,Paul A. Lyons,Kenneth G. C. Smith,Chris Wallace

CLINICAL IMMUNOLOGY（2024）

引用0浏览0WOS引用

AutoPrognosis 2.0: Democratizing Diagnostic and Prognostic Modeling in Healthcare with Automated Machine Learning

Fergus Imrie,Bogdan Cebere,Eoin F McKinney,Mihaela van der Schaar

PLOS digital healthno. 6 (2023): e0000276-e0000276

引用1浏览0EIWOS引用

GWAS meta-analysis and the conditional false discovery rate overcome limited power in a common variant study of rare immunodeficiency

Thomas W. Willis, Effrossyni Gkrania-Klotsa,Paul A. Lyons,Nicholas J. Wareham, Kenneth G. C. Smith,Eoin F. McKinney,Chris Wallace

HUMAN HEREDITYno. SUPPL 1 (2023): 65-65

引用0浏览0引用

UPREGULATION OF THE AP-1 PATHWAY IN SYSTEMIC LUPUS ERYTHEMATOSIS

Prasanti Kotagiri,Laura Bergamaschi,Diana Pombal, Sofie Tolmeijer, Sarah Zanky,Federica Mescia,Eoin Mckinney,Paul Lyons,Ken Smith

NEPHROLOGY（2022）

引用0浏览0引用

Mir-374A-5p Regulates Inflammatory Genes and Monocyte Function in Patients with Inflammatory Bowel Disease

Carlos Perez-Sanchez,Ariana Barbera Betancourt,Paul A. Lyons,Zinan Zhang,Chenqu Suo,James C. Lee,Eoin F. McKinney,Louise K. Modis, Christian Ellson, Kenneth G. C. Smith

The Journal of experimental medicine/The journal of experimental medicineno. 5 (2022)

引用7浏览0WOS引用

100 years post-insulin: immunotherapy as the next frontier in type 1 diabetes (vol 1, ltab024, 2021)

James A. Pearson,Eoin F. McKinney,Lucy S. K. Walker

IMMUNOTHERAPY ADVANCESno. 1 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn